Avacta Life Sciences Limited
  • About
  • Therapeutics
  • Diagnostics
  • Investors
  • News
  • Careers
  • Contact
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • preCISIONTM
    • Affimer®
    • Pipeline
    • Partners
    • Clinical trials
    • Team
    • News
  • Diagnostics
    • Diagnostics
    • Products
    • Affimer®
    • Key benefits
    • Partnering
    • Resources
    • Team
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key information
    • Corporate Governance
    • Documents & Presentations
    • Share price
    • RNS News
  • News
  • Careers
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • preCISIONTM
    • Affimer®
    • Pipeline
    • Partners
    • Clinical trials
    • Team
    • News
  • Diagnostics
    • Diagnostics
    • Products
    • Affimer®
    • Key benefits
    • Partnering
    • Resources
    • Team
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key information
    • Corporate Governance
    • Documents & Presentations
    • Share price
    • RNS News
  • News
  • Careers
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
Home News Blogs
filter by: view all | Blogs | Diagnostics | Investors | Therapeutics

Blogs

08 Mar 2023

Interview with Victoria Statham, VP Intellectual Property & Legal, Therapeutics

Blogs
19 Jan 2022

‘Diagnosing Emerging Variants of SARS-CoV-2 for Effective Transmission Control’ article published in European Biopharmaceutical Review January 2022

Blogs
16 Nov 2021

New Paper: Clinical evaluation of AffiDX® SARS-CoV-2 Antigen Lateral Flow Test

Blogs | Diagnostics
03 Nov 2021

Interview with Fiona McLaughlin – Avacta Chief Scientific Officer, Therapeutics

Blogs | Therapeutics
15 Sep 2021

Lateral Flow Assay Testing for COVID-19 – Tackling asymptomatic spread

Blogs | Diagnostics
24 Mar 2021

Life at Avacta: Interview with Carol Greenlees, Head of Clinical Operations

Blogs
30 Jul 2020

Innovations in neutralising therapies

Blogs | Therapeutics
25 Jun 2020

Responding to disease outbreaks – the importance of point-of-care diagnostics

Blogs | Diagnostics
19 Jun 2020

European Biopharmaceutical Review COVID-19 diagnostics article

Blogs | Diagnostics
18 May 2020

Lab testing vs point of care – how both should be combined to provide full support to communities

Blogs | Diagnostics

Posts navigation

Older posts
Avacta Life Sciences Limited
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Returns & cancellations policy
  • Corporate Responsibility
  • Contact Us

Avacta Diagnostics

Unit 20, Ash Way
Thorp Arch Estate
Wetherby
LS23 7FA
+44 (0)1904 21 7070

virtual tour
email

Avacta Therapeutics

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3871 9700

Investor Enquiries

FTI Consulting
200 Aldersgate
Aldersgate Street
London
EC1A 4HD

Email

Twitter | Linkedin

©2023 Avacta Life Sciences Limited. Registered company no. 06605196.